These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25323886)

  • 1. Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.
    Chung H; Kwon HM; Kim JY; Yoon YW; Rhee J; Choi EY; Min PK; Hong BK; Rim SJ; Yoon JH; Lee SJ; Park JK; Kim MH; Jo M; Yang JH; Lee BK
    Yonsei Med J; 2014 Nov; 55(6):1507-15. PubMed ID: 25323886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China.
    Huang Y; Wu Y; Yang Y; Li W; Lu J; Hu Y
    Sci Rep; 2017 Nov; 7(1):16092. PubMed ID: 29170433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
    Li J; Zhou Z; Niu X; Li H
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
    Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
    Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of age and statin therapy in the interpretation of Lp-PLA(2) in ACS patients, and relation to CRP.
    Franeková J; Kettner J; Kubíček Z; Jabor A
    Physiol Res; 2015; 64(2):229-36. PubMed ID: 25317678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma lipoprotein-associated phospholipase A₂ activity is associated with plaque rupture in patients with coronary artery disease.
    Liu CF; Qin L; Ren JY; Chen H; Wang WM; Liu J; Song JX; Li LJ
    Chin Med J (Engl); 2011 Aug; 124(16):2469-73. PubMed ID: 21933589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of atherosclerotic tissue types in single-vessel and intermediate coronary lesions: a cross-sectional study.
    Wang X; Chen Q; Xu Y; Wang Y; Yang Y; Gu M; Xu H; Zhao Y
    Lipids Health Dis; 2017 Mar; 16(1):63. PubMed ID: 28335787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe periodontitis is associated with the serum levels of hypersensitive C reactive protein and lipoprotein-associated phospholipase A2 in the patients of acute ischemic stroke.
    Chen C; Zhu J; Deng X; Yang Z; Lin W; Ma Y; Huang S; Chen L; Liu Y; Zhu F
    J Clin Neurosci; 2021 Jun; 88():232-236. PubMed ID: 33992190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
    Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
    Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers.
    Ostadal P; Vondrakova D; Kruger A; Janotka M; Psotova H; Prucha M
    Lipids Health Dis; 2012 Nov; 11():153. PubMed ID: 23140470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lipoprotein-associated phospholipase A₂ with characteristics of vulnerable coronary atherosclerotic plaques.
    Liu YS; Hu XB; Li HZ; Jiang WD; Wang X; Lin H; Qin AQ; Wang YM; Zhao T; Dong ZQ; Zhang M; Lu QH
    Yonsei Med J; 2011 Nov; 52(6):914-22. PubMed ID: 22028154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The correlation of human serum Lp-PLA2 and hs-CRP and stability of coronary atherosclerotic plaques].
    Xu DL; Liu JN; Du YM; Yao GH; Jiang WD; Wang X; Dong ZQ; Hao L; Wang GY; Sui SJ; Li JF; Lu QH
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):651-4. PubMed ID: 19954057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
    Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
    Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndrome.
    Li J; Wang H; Tian J; Chen B; Du F
    Medicine (Baltimore); 2018 Jul; 97(28):e11517. PubMed ID: 29995820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
    Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
    PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
    Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
    Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study.
    Kim JY; Hyun YJ; Jang Y; Lee BK; Chae JS; Kim SE; Yeo HY; Jeong TS; Jeon DW; Lee JH
    Am J Clin Nutr; 2008 Sep; 88(3):630-7. PubMed ID: 18779277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.